semaglutide and tirzepatide equivalent doses are highly effective medications for obesity management. Tirzepatide leads to significantly greater loss of weight and waist circumference compared with Semaglutide among adults with obesity but without diabetes Switching from Semaglutide to Tirzepatide:

We encourage a "consistency over intensity" approach

Log In / Sign Up Cagrilintide + Semaglutide is a dual-agonist combination of an amylin analogue and GLP-1 receptor agonist studied in metabolic and endocrine research

Among the anorexigenic peptides, the first recognized inhibitor of food intake in rodents (36) and then in humans (37-40) was cholecystokinin (CCK), the product of duodeno-jejunal endocrine I cells acting via CCK1 receptors on vagal afferent nerves

Osterholm, M

Additionally, regular follow-ups can help in fine-tuning the dosage and addressing any emerging concerns, ultimately leading to a more personalized and effective treatment strategy